Chronobiological Basis of Menopausal Depression: Correcting Misaligned Circadian Rhythms With Sleep and Light Interventions
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Nov 5, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how mood and sleep patterns can be improved during menopause. Researchers want to find out if making changes to sleep timing and using bright light at specific times of the day can help women feel better and sleep more soundly. They will be studying women who are experiencing symptoms of depression during this transition. Participants will have their melatonin levels checked through urine samples, adjust their sleep schedule for one night, spend two weeks using a light box for 30 minutes each day, and fill out questionnaires about their mood and sleep.
To take part in this study, women need to be between 18 and 74 years old, currently experiencing irregular menstrual cycles, and show moderate signs of depression. However, those with certain conditions, like bipolar disorder or severe depression, or those starting new medications that could interfere with the study, won't be eligible. This trial is currently recruiting participants, and it offers a chance to explore new ways to improve well-being during menopause.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Perimenopausal women with irregular menstrual cycles for at least 3 months
- • Above age 18
- • Experiencing at least moderate depression symptoms (i.e., score of at least 10 on PHQ-9)
- Exclusion Criteria:
- • Actively suicidal or psychotic
- • History of bipolar disorder
- • Staring new medications that would affect outcome measures (e.g., melatonin)
- • Those in whom sleep restriction would be ill-advised (e.g., patients with epilepsy or those with occupations whose safety would be compromised).
- • Women whose body mass index (BMI) exceeds the NIH criteria of \<18 or \> than 30
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Barbara Parry, M.D.
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported